|
HS Code |
631752 |
| Product Name | Fraxini Cortex Veterinary Grade API |
| Dosage Forms | Tablets, Injections, Capsules, Powders, Granules, Premix, Solutions |
| Intended Use | Veterinary pharmaceutical manufacturing |
| Main Ingredient | Fraxini Cortex extract |
| Appearance | Fine powder or granulated form |
| Solubility | Slightly soluble in water |
| Purity | ≥98% by HPLC |
| Storage Conditions | Store in a cool, dry place, protected from light |
| Shelf Life | 24 months under recommended storage conditions |
| Packaging | Sealed aluminum foil bags, fiber drums, or as per client requirements |
| Country Of Origin | China |
| Regulatory Status | Veterinary use only, follows local regulations |
| Active Component | Aesculetin and Fraxin |
| Extraction Method | Water or ethanol extraction |
| Standardization | Standardized to content of main actives |
As an accredited Fraxini Cortex Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Sealed, high-grade aluminum foil bag containing 1 kg Fraxini Cortex Veterinary API, labeled for tablets, injections, capsules, powders, granules, premix, and solutions. |
| Shipping | The chemical "Fraxini Cortex Veterinary Grade API" is securely packaged in sealed, tamper-evident containers to ensure product integrity during transit. Shipped via reliable, certified carriers, each batch is accompanied by full documentation. Temperature control and moisture protection are maintained throughout to guarantee safe and compliant delivery worldwide. |
| Storage | **Storage:** Store Fraxini Cortex Veterinary Grade API in a tightly sealed container, protected from light and moisture. Keep at room temperature (15–25°C) in a cool, dry, and well-ventilated area. Avoid exposure to heat, humidity, and incompatible substances. Ensure the storage area is clean, labeled, and intended for pharmaceuticals. Keep out of reach of unauthorized personnel, and follow local regulations. |
Applications of Fraxini Cortex Veterinary Grade API for Tablets, Injections, Capsules, Powders, Granules, Premix, and Solutions in Industrial ManufacturingAs a direct manufacturer, we supply Fraxini Cortex veterinary active pharmaceutical ingredient (API) for major animal health industries. Our material undergoes rigorous process controls to ensure suitability for target applications ranging from oral solid dosage forms to aqueous solutions for veterinary use. Below, we detail typical downstream industrial scenarios in which our product is used by formulators and finished dosage manufacturers. 1. Companion Animal Oral Tablets ManufacturingVeterinary pharmaceutical manufacturers use this API to formulate oral tablets targeting inflammation and hepatic function in dogs and cats. Production starts with API milling and homogenization before blending with premixed excipients. Direct compression or wet granulation is selected based on dosage strength and release profile requirements. Our material’s uniform particle size distribution supports consistent blending, which is essential for multi-dose batch consistency. Downstream tableting facilities enact “blend uniformity” and “dose uniformity” process controls as part of GMP batch release, followed by tablet testing and coating (if required). Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Large Animal Injectable Solution PreparationAPI is solubilized during the aseptic manufacturing of injectable veterinary products, particularly for cattle, sheep, and pigs. Solution preparations require strict control of pH, ionic strength, and solubility enhancers since Fraxini Cortex-derived compounds vary in aqueous solubility. Our API is micronized for efficient dissolution and is sterilized by filtration prior to aseptic filling. Customers integrate this stage just before terminal sterilization or during bulk solution preparation, ensuring compliance with pharmacopeial sterility standards. Manufacturers then fill under Class 100 or ISO 5 cleanroom conditions to supply ready-to-use or multidose vials. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Livestock Feed Premix for Growth and Immunity EnhancementIndustrial feed compounders include our API in premixed vitamin–mineral blends targeting swine, poultry, and cattle. The bulk API is first mixed with inert carriers such as microcrystalline cellulose or corn starch, then blended into large-volume feed mills via automated dosing systems. Real-time in-line mixing ensures API evenness across metric ton batches. Quality control includes pre- and post-blend analysis of actives by HPLC or TLC. Formulators comply with local maximum residue limits (MRLs) and withdrawal times to ensure treated animals enter the food chain safely and in compliance with regional authorities. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Veterinary Capsule Dosage DevelopmentFinished product manufacturers select our API for hard gelatin or HPMC capsule dosage forms aimed at rapid oral absorption in companion animals and valuable livestock. Capsule filling employs vibration or tamping pin machines, prior to capsule sealing and QC inspection. Ingredients may be used as-is or pre-granulated for challenging flow properties. Batch records document the API lot integration at the initial weighing and pre-blending phases. Downstream, capsule line operators run in-process weight and content uniformity checks according to validated protocols and release testing prior to batch packaging. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Soluble Granule Formulations for Poultry and AquacultureThis application integrates our API in soluble granule production for use in poultry and aquaculture operations. Manufacturers granulate the API with dispersing agents and water-dispersible excipients to ensure rapid dissolution in drinking water systems. The process includes precision metering, high-shear granulation, fluid bed drying, and sieve sizing to achieve flow properties compatible with dosing equipment. Final packaging typically uses moisture-barrier laminate pouches to maintain product stability in humid environments. Quality assurance teams check each lot for solubility, dispersibility, and assay compliance before release. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Fraxini Cortex Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Years on the production floor have shown us the difference that raw material quality and reliable processes can make, especially in veterinary active pharmaceutical ingredients (APIs). Our team produces Fraxini Cortex Veterinary Grade API with the same attention to consistency required by tablet, injection, capsule, powder, granule, premix, and solution manufacturers worldwide. Each batch, from extraction to refinement, reflects daily processes shaped by direct feedback from formulation chemists, operators, and veterinary professionals.
Cortex Fraxini, sourced from Ash tree bark, holds a long-standing role in animal health thanks to its bioactive profile. In veterinary applications, the demands for purity, traceability, and reliable specification often outstrip those for food or traditional medicine markets. By overseeing every step, from careful biomass selection to controlled drying and extraction, we produce a grade that fits even the most demanding veterinary purposes. The sensitivity that animals show to trace contaminants makes these steps crucial for every client who trusts our material in their finished products.
In conversations with our clients, we hear frequent concerns about extraction residue, batch-to-batch variation, or solubility issues cropping up in the middle of development. By refining Fraxini Cortex at source, controlling particle size, moisture levels, and key actives such as esculetin and aesculin, our process delivers reliable mixing and consistent dosing. Models available include fine powder graded for tablet and capsule compression, injectable-grade extract for solutions or suspensions, and granulated fractions pre-tested for premix integration. Lab data backs every lot, but insight from veterinarians and manufacturing engineers keeps us improving the real-world application.
Veterinary compounders and feed supplement producers each demand flexibility, but one thing remains clear: active compounds with unpredictable levels undermine end use. We refuse to compromise on specification, preferring to batch-test excipient compatibility in real settings, checking flowability, blend uniformity, and even challenging sampling methods in factory conditions. This results in API lines that support tablet, capsule, powder, or solution development without causing caking, segregation, or mixing problems on actual production lines.
Direct experience tells us that not every format puts Fraxini Cortex to work in the same way. For tablet manufacture, particle size uniformity and flow properties figure largest. Our compressed, micronized powders answer this by blending smoothly, supporting direct compression and uniform tablet hardness. Production teams rely on consistent moisture content to avoid sticking and ensure long punch life. For capsules, the compactability supports precision fill weights, avoiding wastage. In solution and injectable preparations, full testing for solubility and absence of insoluble particles ensures a clear, injectable-grade concentrate, minimizing the need for filtration adjustments on the filling line.
Granule and premix formats benefit from a different approach—here, we focus on agglomerate stability, resistance to dusting, and ease of mixing with base carriers. By modifying drying parameters and parent particle size, we create fractions that let mill operators run longer batches without worrying about separation or inconsistent dosing. Constant dialogue with large-scale premix clients reveals pain points that simply don’t show up in laboratory validation alone, and we use that feedback to adjust production parameters batch by batch.
Clients trust animal health products to deliver what the label promises. We go beyond primary marker testing, monitoring stability of core actives through storage and even during formulation steps. Our in-house research teams have demonstrated that certain drying techniques better preserve esculetin content, while excess heat or moisture swings degrade activity long before expiry. We monitor not only what leaves our plant, but how it ages—by testing lots six months or a year after production, and sharing results with our partners.
Unlike variable crude extracts, our Fraxini Cortex Veterinary Grade API brings documented, repeatable bioactivity. Farm trials alongside laboratory analysis help us bridge the gap between bench-top results and field performance. Production foremen, not just lab scientists, keep tabs on critical steps, as dust control, humidity management, and transfer protocols all affect the final quality. If a method works on a three-ton batch, we keep it; if it breaks down at scale, we rethink.
Across veterinary manufacturing, risk management comes down to prevention. We work under traceable sourcing, with a documented chain from forest harvest to finished drums. Each process step is logged, with full batch records—because having answered regulatory inquiries ourselves, we know that documentation is not a formality. When issues like pesticide residues or heavy metal contamination make headlines, our lot-level segregation, testing and supplier contracts have already addressed the risk. Veterinary manufacturers need partners able to produce not just test reports but real-world examples of failures resolved and lessons applied—not just for regulatory agencies, but to build real trust in the supply chain.
Years ago, our powder line had chronic issues with sieving bottlenecks. A few production stops traced back to too-coarse fractions that passed initial screen specs but underperformed in tablet blends. Resolving those issues demanded collaboration—operators, quality inspectors, even customers facing caking at their own granulators. By tweaking mill settings and implementing in-line screens with real-time sampling, we cut customer complaints by over 80%. For injectable fractions, needle blockage once plagued early customers. We reengineered filtration and clarified the dissolution process, backstopping it with holding-time testing to ensure clarity and low insoluble matter.
Improvement doesn’t start from statistics alone. Batch variabilities in active content prompted us to adjust drying cycles and upgrade our temperature monitoring during the critical finish. A few tenths of a degree made the difference in esculetin preservation, confirmed in on-site pilot tablet production with client partners. Powder handling issues led us to adjust anti-caking treatments and packaging formats; for customers in humid climates, that meant modified triple-lined bags and desiccant use by default.
There are no shortcuts in scaling laboratory findings into large industrial runs. Past mistakes and customer returns have forced us to change. Early granulated batches, for instance, experienced clumping after long-haul sea transport. We redesigned the granule matrix and packaging, reinforced stability trials, and deployed real-world temperature and transport abuse testing. These investments in process, not just machinery, keep our product from failing our partners on the line or in the field.
Our teams know that every kilogram sent out builds a track record. Supporting novel veterinary formulations or standard supplement lines, we answer questions on particle size adjustments, custom blending, and flow improvement—not just as paperwork, but by running small-lot trials in parallel with customer pilot lines. By offering transparency into our raw material selection, process modifications, and even past failures, we give formulation chemists the confidence to scale-up or troubleshoot on a real timeline.
Some customers need extra-fine dispersible powder for oral suspensions. Others ask for coarse fractions to blend into pelleted feed premixes. Each need challenges us to understand the full life cycle—after all, a product that looks perfect at shipment can disappoint after weeks in a warehouse or under high humidity. Our ongoing commitment to sensory evaluation, blend testing, and accelerated aging means we stake our name on every drum.
On the supply side, we’ve seen plenty of generic Fraxini Cortex powder that looks similar at surface glance but fails in veterinary settings. Key problems in those products—variable actives, heavy metal contamination, unstable coloration, poor solubility—are rooted in shortcuts or a focus on non-veterinary markets. Our manufacturing plant runs with full segregation of Fraxini Cortex intended for veterinary use, avoiding cross-contamination with food, cosmetic, or industrial materials. Allergen management and pesticide exclusion policies extend beyond compliance—they shape real purchasing decisions for our direct partners.
Distributors sometimes offer “pharmaceutical grade” without proof—only full chains-of-custody and on-site audits reveal if an API is what it claims to be. Every batch of our veterinary grade Fraxini Cortex comes with provenance data and active content validation by in-house and independent labs, so our customers know they have the documentation to face regulatory audits or internal quality checks.
Production challenges change yearly. As regulatory thresholds shift, environmental contaminants become a concern, or new delivery technologies appear, our team stays connected with research institutions and frontline veterinary researchers. We invest in crop origin monitoring, soil health checks, and look for emerging threats—like aflatoxin contamination risk or climate-driven pest pressure. These issues don’t wait for a crisis, so our systems stay proactive, trialing new farming partners and extraction techniques before supply chain risks close in.
Feedback cycles remain short. When a major customer reported increased dusting during a seasonal air humidity spike, we reviewed not only our own granulation processes but shared moisture-absorption data to help redesign client storage protocols. Shared learning leads to faster response—no plant runs without issue, but prompt, factual communication leads to improvement for both sides.
Questions on compatibility are answered not just by referencing specifications but by pulling actual production data and field experience. For a veterinary laboratory facing unexpected color shift in trial batches, we traced the problem to oxidized minor components, which are harmless but affect customer satisfaction. Adjusting oxygen exposure during storage addressed the problem and restored visual consistency. These feedback loops result in specification and process changes; nothing stays static in a live manufacturing environment.
Tablet hardness fluctuations, often caused by micronization settings or carrier changes, have been solved through joint trouble-shooting and shared pilot-line data. When scale-up creates a powder pickup problem, we offer solutions proven in our own plant, whether that means adjusting blending times or providing pre-lubricated fractions based on customer application.
No matter how mature a product line becomes, there is always opportunity for failures to teach. Unanticipated extrusion challenges, complaints over dissolution times, or transport-induced caking lead us back to process review and, if necessary, changes in standard practice. Maintaining Fraxini Cortex Veterinary Grade API as a trusted component in animal health formulations depends not only on regular lab analysis, but also on staying honest with feedback and historical data—no batch is too old to review, and every process line undergoes regular staff review and retraining.
We know that veterinary practices, animal producers, and feed manufacturers rarely face the same issues as pharmaceutical or supplement companies. Taste, dispersibility, multi-species tolerance, and cost sensitivities matter. Our own trials in poultry, swine, and ruminant settings often uncover issues that might never appear in desk-based formulation. Our staff includes field veterinarians and production engineers who spend time on site, learning where our product supports animal health—and where we need to adapt the process or specification.
As regulatory scrutiny grows, traceability and proof of safety grow in significance. We support our partners with full documentation audits, and, where needed, revise internal procedures to capture new testing regimens or documentation requests. Our record keeping is open to partner scrutiny, and we use each audit as a chance to further reduce risk.
Every blend, granule, and powder we release to the veterinary sector carries both opportunity and risk—for us and for our customers. Supply chain disruption, raw material seasonality, and shifting veterinary health trends all affect outcomes. Our job is to respond with flexibility, speed, and above all, transparency. We work openly with clients, industry groups, regulators, and innovation partners to refine our offering continually, updating specifications and process controls in line with partners’ shifting needs.
Over years of feedback and shared troubleshooting, we have learned that Fraxini Cortex Veterinary Grade API delivers lasting value not merely by meeting base specifications, but by supporting every manufacturer through production and market challenges. The road from raw bark to finished product runs through our facility, and each process improvement—whether in extraction, drying, blending, packaging, or documentation—reflects both scientific progress and old-fashioned, on-the-floor experience.
Our confidence in Fraxini Cortex Veterinary Grade API stems from the countless problems solved, the production lines optimized, and the veterinarians who rely on our consistency. We view every new project and customer inquiry as a chance to prove, again, that manufacturing integrity delivers far more than just commodities: genuine support built on a foundation of evidence and daily practice, supporting animal health with every batch.